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Abstract: Introduction: Osteoporosis (OP) is a major, highly prevalent health problem and osteoporosis-related fractures 
account for high morbidity and mortality. Therefore, prevention and early detection of osteoporosis should strive to 
substantially reduce this risk of fracture. 
Objective: The present observational, descriptive, cross-sectional study sought to assess the prevalence of risk factors for 
osteoporosis and fractures in a large sample of postmenopausal women aged 50 to 65 years attending Primary Care 
facilities in Spain. 
Methods: We recruited 4,960 women, at 96 Primary Care centers. Demographic and anthropometrical data, as well as 
information regarding risk factors for OP were collected using a questionnaire. 
Results: The prevalence rates for the major osteoporosis risk factors in our population were: low calcium intake, 43%; 
benzodiazepine use, 35.1%, and height loss, 30.1%. Other relatively prevalent factors include: having suffered at least one 
fall during the preceding year; positive family history of falls (particularly on the mother’s side), smoking, kyphosis, 
presence of any disease affecting bone metabolism, personal history of falls, and inability to rise from a chair without 
using one’s arms. The least frequent factors were weight loss of greater than 10% over the preceding 10 years and 
problems in sensory perception that affect patient’s ability to walk. 
Conclusions: The main risk factors for osteoporosis in women 50-65 years of age are low calcium intake, use of 
benzodiazepines, and observed loss of height. Our results may help physicians to identify groups at risk for OP and 
fractures at early stages and consequently, optimize prevention and early diagnosis of osteoporosis in postmenopausal 
women. 
Keywords: Postmenopausal women, risk factors, osteoporosis, primary health care. 
INTRODUCTION 
  Osteoporosis (OP) is a highly prevalent disease 
particularly in postmenopausal women, characterized by 
decreased bone density resulting in increased susceptibility 
to fracture [1, 2]. The clinical relevance of OP is derived not 
only from the increase in morbidity and mortality, but also 
the pain, physical impairment, and loss of functional ability 
that have an important impact on patients’ quality of life. It 
also entails significant cost to society: hospitalization costs 
are increased as are medical tests, length of stay in nursing 
homes and consulting rooms, as well as the costs associated 
with patients’ diminished activity [3-5]. According to the 
World Health Organization (WHO), 30% of Caucasian   
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women over the age of 50 suffer from OP versus 8% in 
males [6].
 In Spain, 17.2% of females aged 50-60 years may 
suffer from OP. The percentage of affected women rises to 
40% between 60-70 years of age [7]. 
  OP is a chronic disease requiring chronic treatment. 
However, as this condition produces little or no symptoms, 
patients go undiagnosed until a fracture occurs and the 
osteoporosis is more severe. Hence, disease prevention and 
early diagnosis are particularly important. Nevertheless, 
effective diagnostic tools are currently not available to assist 
Primary Care physicians in detecting individuals at risk for 
developing OP and associated fractures in the future. 
Identifying OP risk factors will aid Primary Care physicians 
in selecting patients for evaluation and intervention. 
  That is why it is important to assess not only the risk 
factors associated with osteoporosis per se, which are fairly 
well-known, but also their prevalence in the general 
population. Several studies have shown that there are many Risk Factors for Osteoporosis in Women 50-65 Years  The Open Rheumatology Journal, 2008, Volume 2    59 
risk factors that need to be taken into account: age, early 
menopause, history of previous fractures, family history, 
being underweight or treatment. The prevalence of these 
factors has been analyzed [8-10] however, most of these 
studies have been conducted in women over the age of 65 
years. 
  Consequently, little information is available on the most 
prevalent risk factors for OP in postmenopausal women aged 
50-65 [11, 12] which is where OP prevention schemes 
should be focused on substantially decreasing the incidence of 
OP and fractures. 
  This study sought to assess the prevalence of risk factors 
for osteoporosis and fractures in a large sample of 
postmenopausal women aged 50 to 65 years cared for at 
Primary Care facilities in Spain. 
MATERIALS AND METHODS 
Study Design 
  An observational, cross-sectional, descriptive study was 
designed to analyze the prevalence of different OP risk 
factors. The study was conducted at Primary Care centers 
belonging to the public healthcare system in Spain. The 
distribution of sites (100 sites planned) across the Spanish 
geography and sample size (50 patients per site) was 
calculated on the basis the number of patients with this 
specific age according the 1998 Census by quotes and 
geographic distribution to achieve a truly representative 
sample. 
  Dedication to the study was reimbursed according to 
European Medicines Evaluation Agency (EMEA) guidelines 
for studies of this kind [13]. The protocol was approved by 
an independent review board. 
Patients and Procedures 
  Postmenopausal women with ages between 50 and 65 
years attending a routine visit with any of the participating 
physicians were invited to participate in the study, regardless 
of the reason for consultation. A signed authorization for the 
collection and use of clinical data in accordance with 
standing regulations regarding personal data protection was 
obtained from all subjects prior to enrollment. Patients 
participating in any other clinical study of OP drug treatment 
were excluded. 
  Demographic, anthropometric, and risk factors for OP 
and fracture data were recorded for patients included in the 
study using a 14-item questionnaire administered by 
physician. The questionnaire included the following 
information: personal data (date of birth, age at menarche, 
age at onset of menopause, type of menopause, number of 
children), physical examination (weight, height, pulse), 
osteoporosis and fracture risk factors (weight loss greater 
than 10% in the last 10 years or if the loss it has compared 
with in weight that it had to the 35 years, loss of height, 
kyphosis, disturbances of sensory perception, number of falls 
in the previous year, ability to stand up from a chair 
unaided), patient life style factors (dietary consumption of 
dairy products in mg, physical activity, cigarette smoking), 
personal history of previous fragility fractures (excluding 
trauma fractures), family history of osteoporotic fracture 
(father, mother, or sisters), prior and present use of drugs 
affecting bone metabolism (bisphosphonates, HRT, calcito-
nins, calcium and vitamin D, raloxifene, tibolone), drugs that 
increase the risk of osteoporosis or fractures (anticonvul-
sants, thyroid hormones, oral and inhaled glucocorticoids, 
oral anticoagulants, benzodiazepines, antiarrhythmics, oral 
insulins, hypoglycemics, lithium), and disorders that affect 
bone metabolism and increase the risk of falls (chronic liver 
disease, Cushing’s syndrome, hyperparathyroidism, stroke, 
malabsorption syndromes, secondary amenorrhea lasting at 
least one year, obstructive pulmonary disease, rheumatoid 
arthritis, urolithiasis, Parkinson’s disease, hyperthyroidism, 
gastrectomy, and type I diabetes). 
Statistics 
  Quantitative variables were described in terms of mean 
and median values, as well as typical deviation, first and 
third quartile, and range (maximum and minimum values). 
They are analyzed using an ANOVA model. Qualitative 
variables were described by frequency and percentage and 
analyzed using the Chi square test or, if not applicable, by 
means of Fisher’s exact test. The 95% confidence intervals 
are used for all variables. 
  Patients were included on an intention-to-treat (ITT) 
basis. 
RESULTS 
  A total of 4960 women were screened for the study over 
a 10-month period (July 2002-April 2003) at 96 primary care 
centers. All patients signed the inform consent. Sixty-two 
patients were excluded because they did not meet inclusion/ 
exclusion criteria (mainly age). As a result, 4898 patients 
were finally included in the analysis and distributed into 
three age subgroups: 39% of the patients were 50-55 years of 
age (n=1905), 28% were 56-59 (n= 1378), and 33% were 60-
65 (n=1615). 
  General characteristics (N=4898) are summarized in 
Table 1. No significant differences were observed between 
age groups for physical characteristics on the whole; we 
therefore examined more detailed data for the entire group. 
Mean age at menarche was 12.87 (SD: 1.6), slightly higher 
in the 60-65 year age group (13.6). Mean age at onset of 
menopause was 48.5 (SD: 4.5). Menopause was natural in 
84.9% of the subjects. The data collected from the physical 
examination yielded a mean weight of 69.7 kg and mean 
height of 157 cm. Mean body mass index was 28.3 kg/m
2 
indicating that our population is somewhat overweight. 
  The prevalence of risk factors is detailed in Table 2. 
According to the data obtained, factors with a prevalence 
rate greater than 30% are: low calcium intake ( 600mg/ day, 
measured by dairy product intake), 43%; use of drugs that 
can influence bone metabolism and/ or increase the risk of 
fracture, 35.1%; lack of physical activity (defined as no 
intentional physical activity declared by the patient), 31.8%, 
and observed height loss throughout the patient’s life, 
30.4%. 
  Other OP and fracture risk factors detected in our 
population included: having suffered at least one fall over 
the preceding year (22.8%). This percentage increased with 
age: 17.7% in the 50-55 year group; 23.2% in the 56-59 year 
old group, and 28.7% in the women aged 60-65 years. 60    The Open Rheumatology Journal, 2008, Volume 2  Rentero et al. 
Insofar as the prevalence of previous osteoporotic fractures 
is concerned (see Table 3), 10% of all patients had had at 
least one fracture in the past with the forearm the most 
common fracture site (35%). Twenty-two percent of the 
patients had a positive family history of osteoporotic 
fracture(s) (22.3%), predominantly on their mother’s side 
(17.5%). 
  Other factors were presence of kyphosis (18.7%), 
observed weight loss greater than 10% over the previous 10 
years (8%), inability to rise from a chair without using one’s 
arms (10%), problems in sensory perception affecting the 
patient’s ability to walk (from 5.5% to 9% depending on age 
group), and lifestyle-related factors such as, current or past 
smoking (21%). 
  Strikingly, 30.2% of the study subjects were taking any 
medication for OP (Table 4) and of them, 8.1% were only 
taking calcium and/or vitamin D. 
Table 3.  Site of Prior Osteoporotic Fracture (n= 505) 
 
  Number of Fractures  %* 
Forearm 179  3.65 
Foot 103  2.10 
Leg 89  1.81 
Vertebra 48  1.0 
Humerus 30  0.6 
Sternum/ Ribs  17  0.34 
Hip 16  0.32 
Clavicle/ Scapula  10  0.2 
Sacrum/ Coccyx  9  0.18 
*Calculated from the total study population N=4898. 
 
Table 1.  General Characteristics (N=4898) 
 
 Mean  SD  95%  CI  Median 
Age at menarche (years)   12.87  1.6  12.8-12.9  13 
Age at onset of menopause (years)  48.49  4.5  48.4-48.6  49 
Number of children   2.46  1.5  2.4-2.5  2 
Weight (kg)  69.7  11.8  69.4-70.0  68.5 
Height (cm)  157.08  6.6  156.9-157.2  157 
Body Mass Index  28.31  4.9  28.2-28.5  27.7 
Number of falls in the preceding year  1.96  2.86  1.79-2.13  1 
Number of hours of physical activity/ week  3.9  4.9  3.7-4.1  3 
 
Table 2.  Prevalence of OP and Fracture Risk Factors (N=4898) 
 
 
50-55 Years  
N=1905 
(%) 
56-59 Years 
N=1378 
(%) 
60-65 Years 
N=1615 
(%) 
Total 
N=4898 
(%) 
Chi-Square 
p-Value 
Dairy product intake (600 mg/ day)  773 (40.6)  600 (43.5)  738 (45.7)  2111 (43.1)  0.0087 
Observed height loss  448 (23.5)  410 (29.8)  632 (39.1)  1490 (30.4)  <0.0001 
Observed weight loss 10% in 10 years  141 (7.5)  111 (8.1)  145 (9.0)  398 (8.1)  0.2971 
Patients with at least one fall in the preceding year  337 (17.7)  319 (23.2)  463 (28.7)  1119 (22.8)  <0.0001 
Presence of kyphosis  266 (14.0)  255 (18.5)  395 (24.5)  916 (18.7)  <0.0001 
Inability to rise from a chair without using one’s arms  166 (8.7)  128 (9.3)  196 (12.1)  490 (10.0)  0.0009* 
Problems in sensory perception affecting patient’s ability to 
walk  104 (5.5)  91 (6.6)  146 (9.0)  341 (7.0)  <0.0001* 
Current and past smoking status  610 (32.0)  251 (18.2)  212 (13.1)  1163 (21.9)  <0.0001* 
Lack of physical activity  601 (31.5)  421 (30.6)  534 (33.1)  1556 (31.8)  0.334 
Personal history of osteoporotic fracture  136 (7.1)  123 (8.9)  246 (15.2)  505 (10.3)  <0.0001* 
Family history of osteoporotic fracture  415 (21.8)  300 (21.8)  379 (23.5)  1094 (22.3)  0.1749 
Mother  (18.2) (17) (17.2)  (17.5)  0.5869 
Use of drugs that can influence bone metabolism and/ or 
increase risk of fracture: current or past  570 (29.9)  506 (36.7)  642 (39.8)  1718 (35.1)  <0.05 
Presence of bone metabolism disorder or disease that increases 
risk of falls  194 (10.2)  145 (10.5)  246 (15.2)  585 (11.9)  <0.05 
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  As mentioned previously, 35% of the patients were 
taking drugs that could influence bone metabolism and/ or 
increase the risk of fracture (Table 4), the most frequent of 
which were: benzodiazepines (36%), thyroid hormones 
(5.5%), and oral antidiabetic agents (4.2%). 
Table 4.  Drugs to Treat Bone Metabolism Disorder and those 
that can Affect Bone Metabolism 
 
 %* 
Drugs to treat bone metabolism disorder: current use  
Calcium   16.9 
Hormone replacement therapy  7.4 
Vitamin D  7.2 
Raloxifene 7.3 
Biphosphonates 4.6 
Calcitonin   1.3 
Tibolone 2.2 
Drugs that can affect bone metabolism: past or current use 
Benzodiazepines 22.6 
Thyroid hormones  5.5 
Hypoglycemics 4.2 
Inhaled glucocorticoids  2.8 
Oral glucocorticoids  2.6 
Anticoagulants 1.9 
Antiarrythmics 1.8 
Insulins 1.2 
Anticonvulsants 1.1 
Lithium 0.3 
*Calculated from the total study population N=4898. 
 
  Additionally, 11% of the participants were suffering from 
a bone metabolism disorder or a disease that increases the 
risk of falls; the most common of them were: urolithiasis in 
3.7% and hypothyroidism and chronic pulmonary 
obstructive disease, both in 1.7% of the patients and 
reumatoid arthritis in 1.5% of patients. 
DISCUSSION 
  The present naturalistic study reveals the prevalence of 
various risk factors in postmenopausal women aged 50 to 65 
years visiting their physician for routine consultation. 
  From our results, the most prevalent OP and fracture risk 
factors (over 30%) are low calcium intake (less than 600 mg/ 
day), use of drugs that affect bone metabolism (mainly 
benzodiazepines), and observed height loss, followed by lack 
of any physical activity. There is another important group of 
moderately prevalent factors (10-23%) including: having had 
at least one fall in the last year; family history of falls 
(especially on the mother’s side), cigarette smoking, 
kyphosis, presence of a disorder affecting bone metabolism, 
personal history of falls, and inability to stand up from a 
chair without using one’s arms. The least frequent risk 
factors observed were weight loss greater than 10% in the 
last 10 years and problems in sensory perception that affect 
patient’s ability to walk. 
  When relating the prevalence of the different risk factors 
found in our study with the relative importance of those 
factors with respect to osteoporosis as assessed in a 
published review [14], we have detected differences between 
both concepts. Some of the factors considered as high risk 
had a low prevalence; hence, their final importance may in 
fact be relative. 
  According to our study, with the exception of age, 
considered to be a high risk factor when over 70 years and 
therefore excluded from our study population, there is only 
one high risk factor that also displayed a high prevalence rate 
– physical inactivity. This is consistent with the findings of a 
retrospective review of the prevalence of risk factors in a 
general female population aged 50 years and older [15] and 
also with the improvements in dynamic balance and strength, 
both important determinants of risk for falls in a community-
based exercise program conducted in a randomized control 
trial [16]. Van der Voort et al. also reports that practicing 
sports, even in the past, exhibited a slightly positive 
relationship with the patients’ fractures [17]. 
  Other important high risk factors that were identified are 
personal history of osteoporotic fracture [18, 19] and weight 
loss [14]. Nevertheless, both of them had a prevalence rate of 
approximately 10% in our study, which seems reasonable 
compared with the older population, due to the shorter time 
of deterioration given the fact that our population was 
younger. 
  The personal history of fracture reported in older women 
ranged from 39.2% to 24.3% [8, 20, 21].
 The figure from a 
Spanish population was a lower (20.1%) [10], perhaps due to 
the lower incidence of osteoporotic fracture in the Spanish 
population versus the USA [22]. Nevertheless, data from our 
study yield a much lower figure of 10.3%; this is in line with 
studies in younger populations (patients over the age of 45 
years) that present rates that range from 8 to 10% [23-25]. 
Weight loss had been considered to be the best predictor of 
low bone mineral density in elderly women [26], however it 
seems that it is less important in women under 65 years of 
age. 
  On the other hand, some of the moderate risk factors [14] 
were highly prevalent in our study population. We have 
established that low calcium intake was the most prevalent 
factor found in the study (43%). This deficiency was not 
compensated with calcium supplements as only 16.9% of 
study population was taken this type of supplements. 
Remarkably, only 22,1% of patients were taking specific 
medication for OP. 
  A positive family history of osteoporotic fracture, 
particularly on the mother’s side, was also highly prevalent 
in our study population, 22.3%, albeit lower than data 
published in the literature that has been cited at around 30% 
[23, 27]. This seems reasonable since our population was 
younger, so that their families (mainly mother and sisters) 
were also younger and had less osteoporosis fractures. Once 
again, this difference can be attributed the lower incidence of 
osteoporotic fracture in the Spanish population versus the 
USA [22]. 62    The Open Rheumatology Journal, 2008, Volume 2  Rentero et al. 
  Another well-known risk factor [28], smoking, was 
present in 22% of our study population. Current and past 
cigarette smoking is the only factor that differed significantly 
in terms of prevalence between the different age groups in 
our study. The highest prevalence for this factor, 32.1%, was 
found in the youngest group (50-55 years) compared to the 
other two groups: 18.2% in the 55-60 year-old group and 
13.1% in the oldest age group (60-65 years). This difference 
is easily accounted for if we consider lifestyle changes and 
increased rates of smoking among the female population in 
Spain. It is also consistent with the results obtained in the 
ESOPO study in premenopausal women [29], which 
concluded that bone stiffness was negatively correlated to 
age and number of cigarettes and positively related to body 
weight, body weight at age 25, height, and estimated daily 
calcium intake in this special population. Nevertheless, data 
regarding smoking is highly variable in the literature because 
of the idiosyncratic, sociological influence on this range 
[10].
 
  Similarly, the use of drugs that can influence bone 
metabolism and/ or increase risk of fracture is also 
conditioned by sociological idiosyncrasies. Different clinical 
and prescription habits can explain the high prevalence of 
benzodiazepine-based treatment that was consistent with 
another Spanish study carried out in an older patient 
population [10] but significantly higher than other published 
studies reporting data of approximately 9% [20, 21]. This is 
also the case with thyroid hormone use – our study detected 
a 5.5% rate of thyroid hormone use; a 3.5% rate is reported 
in the older Spanish population and between 11-18% in other 
literature reports
 [20, 24, 30]. 
  This study has the inherent limitations owing to its 
naturalistic design. For instance, we cannot exclude the 
possibility of recall bias due to seft-report of information 
regarding risk factors and history of previous fractures, 
despite the evidence indicating that self-report is highly 
accurate [31, 32]. Another limitation is that patients included 
into the study were those attending a routine visit to a 
Primary Care centers and are not general population. This 
inconvenience was minimized by selecting patients by 
quotes per age and geographic distribution according the 
1998 Census to achieve a truly representative sample and 
offers them the study regardless of the reason for 
consultation. It is also noticeable that the prevalence of the 
risk factors identified may not reflect the actual importance 
of their contribution to osteoporosis, being for example of 
low frequent but high impact on the osteoporosis disease. 
  As we have already seen in the discussion, it is highly 
subject to idiosyncratic influences (for example: drug 
prescription, smoking habits…), but there are other general 
factors whose prevalence are of great overall relevance. 
  This is the first study to show the prevalence of risk 
factors for OP and fractures in a large sample of 
postmenopausal patients aged 50-65 years in a Primary Care 
setting. In contrast with the  65 years series [8-10] there are 
some factors that are found to be more prevalent in our 
population: low calcium intake (including low percentage of 
patients taking calcium or vitamin D), smoking habits, and 
family history of osteoporosis. With age, other factors take 
on greater relevance, such as personal history of osteoporotic 
fracture, other concomitant diseases, and the use of drugs 
that can influence bone metabolism, weight loss, etc… [33, 
34].
 
  Taking into account that age itself is a clearly defined 
risk factor, it seems evident that other factors are of different 
relevance depending on patients’ age; it will therefore be 
extremely valuable to have data about different factors at 
different ages. 
  Identifying prevalence factors in this younger population 
is especially important because, while certain risk factors 
such as age and gender can obviously not be modified, there 
are other risk factors such as calcium or vitamin D 
deficiency that can, at least theoretically, be changed [35]. 
CONCLUSIONS 
  As we have pointed out, the relevance of the different 
risk factors for osteoporosis and fractures in postmenopausal 
women factors are clearly dependence on patients’ age. 
According our results, the main factors for osteoporosis in 
postmenopausal women 50-65 years of age in the Primary 
Care setting are low calcium intake, benzodiazepine use, and 
observed height loss. Our results may help physicians to 
identify groups of patients who are at risk for OP and 
fracture at early stages and subsequently optimize prevention 
and/ or early diagnose of osteoporosis in postmenopausal 
women. 
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